Reaction
Diaphragmatic Paralysis reporting signals
As of the last recalculation, Diaphragmatic Paralysis appears in 598 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is BUPIVACAINE (PRR 49.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bupivacaine | 13 | 49.5 | 49.5 |
| Cefepime | 9 | 22.2 | 22.2 |
| Cefepime Hydrochloride | 10 | 22.0 | 22.0 |
| Mesna Injection | 5 | 21.2 | 21.2 |
| Rocuronium Bromide | 7 | 20.9 | 20.9 |
| Mesna | 5 | 20.8 | 20.8 |
| Sevoflurane | 4 | 16.9 | 16.9 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 4 | 12.7 | 12.7 |
| Naltrexone | 11 | 12.6 | 12.6 |
| Botulinum Toxin Type A | 4 | 11.3 | 11.3 |
| Dornase Alfa | 6 | 10.7 | 10.8 |
| Benralizumab | 5 | 8.8 | 8.8 |
| Palivizumab | 3 | 6.8 | 6.8 |